
Ividence helps pharma and life sciences teams speed drug development by turning real-world data into actionable insights. It uses causal machine learning, target trial emulation, generative AI, digital twins, and privacy-preserving federated learning. The platform covers all phases of drug development (Phases I–IV) and supports AI-powered systematic reviews and meta-analyses. Key tech includes ML, causal inference, and generative AI integrated with real-world data, enabling end-to-end workflows and partner data privacy. The company targets biotech and pharmaceutical customers seeking scalable, data-driven decision making.

Ividence helps pharma and life sciences teams speed drug development by turning real-world data into actionable insights. It uses causal machine learning, target trial emulation, generative AI, digital twins, and privacy-preserving federated learning. The platform covers all phases of drug development (Phases I–IV) and supports AI-powered systematic reviews and meta-analyses. Key tech includes ML, causal inference, and generative AI integrated with real-world data, enabling end-to-end workflows and partner data privacy. The company targets biotech and pharmaceutical customers seeking scalable, data-driven decision making.